School of Research
Short Code:
SoR
'Standard States of Bacteria: Nutrient-Limited and Growing Slowly'
Abstract:
‘Macrophages: Bad actors in Cancer ’
‘Tracking Jak-STAT signalling in inflammation ’
All Welcome
‘Environment – Genex interaction in Crohn’s disease’
Biography:
“The evolution of cell division”
11th Scottish Institute for Cell Signalling Lecture - “Mechanistic basis of membrane protein insertion”
Ramanujan Hegde earned his MD and PhD from UCSF in 1999, completing his thesis work in the laboratory of Vishwanath Lingappa. He then started his own laboratory at the US National Institutes of Health, rising to the position of Senior Investigator.
Peter Garland Lecture 2019
More details to follow.
Dundee scientist front and centre of the PROTAC revolution
In an article in the journal Nature, Megan Scudellari reflects on the short history of PROTACs - a new type of drug design that is galvanising the Pharmaceutical industry, with the first PROTAC drug from Arvinas about to enter phase-1 clinical trials.
"New genetic approaches for antimalarial target discovery"
The repeated emergence of antimalarial resistance underscores the importance of identifying new drug targets, as well as understanding the genetic architecture of current resistance pathways and any associated fitness costs. We are developing approaches that combine CRISPR-Cas9 genome editing of P.